Drug Discovery in Preclinical Research
The chief impartial of pre-clinical studies is to define the safe dose for first-in-man study and assess a product's safety profile. Pre-clinical development also recognized as pre-clinical studies and non-clinical studies .In the drug development, preclinical development, is a phase study which prior to earlier clinical trials can begin, and during which important possibility, iterative testing and drug safety data is composed. Generally, only one in every 5,000 compounds that arrives drug discovery to the stage of pre-clinical development befits as an approved drug. These pre-clinical studies involve local toxicity studies such as acute, sub-acute, chronic toxicity studies and systemic toxicity studies such as genotoxicity and carcinogenicity studies.
- Drug metabolism
- Drug design
- Genomics
- Inflammation and Immunology
- Nanotechnology in drug discovery
- Pharmaceutical biotechnology
Related Conference of Drug Discovery in Preclinical Research
Drug Discovery in Preclinical Research Conference Speakers
Recommended Sessions
- Cardiovascular Drug Discovery
- Clinical Trials and Regulatory Affairs
- Computational Molecular Biology
- Computer Aided Drug Design (CADD)
- Drug Delivery and Targeting
- Drug Designing and Molecular Modelling
- Drug Discovery and Development
- Drug Discovery in Preclinical Research
- Medicinal Chemistry in Modern Drug Discovery
- Nanotechnology in Drug Discovery
- Natural products Drug Discovery
- Novel Therapeutics in Drug Designing
- Pharmaceutical and Biomedical Analysis
- Pharmaceutical Biotechnology and Clinical Drug Evaluation
- Pharmaceutical Formulation
- Pharmaceutical Research and Development